| Literature DB >> 32642137 |
Ze-Guo Zhuo1, Gang Li2, Han-Yu Deng1, Jun Luo1, Gu-Ha Alai1, Yun-Cang Wang2, Yi-Dan Lin1.
Abstract
BACKGROUND: The association between the preoperative condition of the esophagus and anastomotic leakage has seldom been studied. We observed a dominant dilation of the esophagus under barium esophagography in some esophageal cancer patients. In consideration of the larger circular stapler are applied in colorectal surgery, we wonder if larger circular stapler should be applied in these patients to fit the larger esophagus. The larger size of the circular stapler also could decrease the incidence of anastomosis stricture. Thus, we made this study to explore if patients with a dilated esophagus were facing a higher risk of anastomotic leakage when applying the 25 mm circular stapler.Entities:
Keywords: Esophagus; anastomotic leakage; risk factor
Year: 2020 PMID: 32642137 PMCID: PMC7330295 DOI: 10.21037/jtd.2020.03.99
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 3.005
Figure 1Measurement protocols of the intraluminal diameter by barium esophagography. (A) Measurement of intraluminal diameter at the level of 5 cm away from the upper margin of the tumor; (B) the level of 5 cm away from the upper margin of the tumor was just behind the aortic arch, the measurement level changed to the upper margin of the aortic arch. Line A: a line 5 cm away from the upper margin of the tumor. Line B: the intraluminal diameter.
Baseline characteristics of patients included in the study
| Characteristics | LG (n=31) | NLG (n=401) | P value |
|---|---|---|---|
| Gender | 0.962* | ||
| Male | 26 (83.9%) | 335 (83.5%) | |
| Female | 5 (16.1%) | 66 (16.5%) | |
| Age (mean ± SD, year) | 65.13±9.08 | 62.41±8.29 | 0.082** |
| BMI (mean ± SD, kg/m2) | 22.84±2.74 | 22.21±3.00 | 0.255** |
| Duration of dysphagia (mean ± SD, month) | 3.58±4.70 | 3.19±3.21 | 0.528** |
| Smoking history | 0.718* | ||
| Yes | 22 (71.0%) | 272 (67.8%) | |
| No | 9 (29.0%) | 129 (32.2%) | |
| Alcohol consumption | 0.703* | ||
| Yes | 21 (67.7%) | 258 (64.3%) | |
| No | 10 (32.3%) | 143 (35.7%) | |
| Diabetes | 0.064* | ||
| Yes | 4 (12.9%) | 18 (4.5%) | |
| No | 27 (87.1%) | 383 (95.5%) | |
| Hypertension | <0.001* | ||
| Yes | 17 (54.8%) | 72 (18.0%) | |
| No | 14 (45.2%) | 329 (82.0%) | |
| Neoadjuvant therapy | 0.312* | ||
| Yes | 1 (3.2%) | 4 (1.0%) | |
| No | 30 (96.8%) | 397 (99%) | |
| Surgery type | 0.321* | ||
| MIE | 2 (6.5%) | 14 (3.5%) | |
| OE | 29 (93.5%) | 387 (96.5%) | |
| Surgeon | 0.967* | ||
| Surgeon A | 14 (7.5%) | 172 (92.5%) | |
| Surgeon B | 8 (6.8%) | 110 (93.2%) | |
| Other surgeons | 9 (7.0%) | 119 (93.0%) | |
| Maximum size of the tumor (mean± SD, cm) | 4.46±1.93 | 4.17±1.79 | 0.377** |
| Anastomosis position | 0.986* | ||
| Above aortic arch | 22 (71.0%) | 284 (70.8%) | |
| Beneath aortic arch | 9 (29.0%) | 117 (29.2%) | |
| Pathologic T stage | 0.291* | ||
| T1−T2 | 8 (25.8%) | 141 (35.2%) | |
| T3−T4 | 23 (74.2%) | 260 (64.8%) | |
| Pathologic N stage | 0.632* | ||
| N0 | 14 (45.2%) | 199 (49.6%) | |
| N1-N3 | 17 (54.8%) | 202 (50.4%) | |
| Pathologic TNM stage | 0.576* | ||
| Stage I−II | 14 (45.2%) | 202 (50.4%) | |
| Stage III−IVa | 17 (54.8%) | 199 (49.6%) | |
| IFPD (mean ± SD, cm) | 1.73±0.60 | 1.60±0.47 | 0.144** |
| IMPD (mean ± SD, cm) | 1.95±0.57 | 1.70±0.52 | 0.010** |
*, P value from Chi-squared test or Fisher’s exact test for dichotomous data; **, P value from Student’s t-test for continuously distributed data. LG, leakage group; NLG, no leakage group; SD, standard deviation; BMI, body mass index; cm, centimeter; MIE, minimal invasive esophagectomy; OE, open esophagectomy; IFPD, intraluminal filling phase diameter; IMPD, intraluminal mucosal phase diameter.
Figure 2ROC curve shows the cutoff value of the intraluminal mucosal phase diameter (IMPD) for distinguishing anastomotic leakage patients. ROC, receiver operating characteristic.
Tendency of leakage rate as the escalation of the IMPD
| IMPD | leakage | No leakage | Leakage rate (%) | P value* |
|---|---|---|---|---|
| IMPD <1.29 cm | 4 | 85 | 4.49 | 1.000 |
| 1.29≤ IMPD <1.79 cm | 7 | 157 | 4.27 | Ref |
| 1.79≤ IMPD <2.29 cm | 14 | 111 | 11.20 | 0.025 |
| IMPD ≥2.29 cm | 6 | 48 | 11.11 | 0.066 |
| Total | 31 | 401 | 7.2 |
*, P value from Chi-squared test or Fisher’s exact test. Ref, reference; IMPD, intraluminal mucosal phase diameter.
Multivariate analysis of the risk factors for the development of anastomotic leakage
| Factors | Wald c2 value | OR | 95% CI | P value* |
|---|---|---|---|---|
| Age ≥65 years old | 0.789 | |||
| No | Ref | |||
| Yes | 0.07 | 1.11 | 0.50–2.47 | |
| Diabetes | 0.298 | |||
| No | ref | |||
| Yes | 1.08 | 1.96 | 0.55–7.00 | |
| Hypertension | <0.001 | |||
| No | ref | |||
| Yes | 16.18 | 5.27 | 2.35–11.85 | |
| IMPD ≥1.79 cm | 0.005 | |||
| No | ref | |||
| Yes | 7.96 | 3.16 | 1.42–7.03 |
*, P value from Wald test. Ref, reference; SD, standard deviation; IMPD, intraluminal mucosal phase diameter.
Factors correlate to the dilated IMPD of the esophagus
| Factors | Spearman’s correlation coefficient | P value* |
|---|---|---|
| Age | −0.098 | 0.042 |
| Male gender | 0.153 | 0.001 |
| Duration of dysphagia | 0.106 | 0.027 |
| Maximum tumor size | 0.169 | <0.001 |
| Pathologic TNM stage | 0.149 | 0.002 |
*, P value from Spearman’s correlation test. The Spearman’s correlation coefficients are positive in male gender, duration of dysphagia, tumor size, and pathologic stage, so they have a positive correlation with dilated IMPD. Age has a negative relationship with dilated IMPD. IMPD, intraluminal mucosal phase diameter.